Late results of alternate treatment of multiple sclerosis with encorton and decaris

A group of 18 patients with clinically definite multiple sclerosis were subjected to alternate treatment with Prednisone (Polfa) and Decaris (Richter). The results were compared with those in a control group of 18 cases treated exclusively with Prednisone during exacerbations of the disease. The res...

Full description

Saved in:

Bibliographic Details
Published in:	Neurologia i neurochirurgia polska Vol. 25; no. 2; p. 149
Main Authors:	Wender, M, Tokarz-Kupczyk, E, Mularek, O
Format:	Journal Article
Language:	Polish
Published:	Poland 01-03-1991
Subjects:	Adjuvants, Immunologic - administration & dosage Adult Disability Evaluation Drug Administration Schedule Female Humans Immune Tolerance - drug effects Immune Tolerance - immunology Levamisole - administration & dosage Male Middle Aged Multiple Sclerosis - drug therapy Multiple Sclerosis - immunology Prednisone - administration & dosage Time Factors
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A group of 18 patients with clinically definite multiple sclerosis were subjected to alternate treatment with Prednisone (Polfa) and Decaris (Richter). The results were compared with those in a control group of 18 cases treated exclusively with Prednisone during exacerbations of the disease. The results indicate that the alternate treatment has not any significant effect on the course of multiple sclerosis, evaluated by the Kurtzke disability scale. The alternate treatment with a mild immunosuppression Encorton and immunomodulation-Decaris (Levamisole) leads to significant decrease of relapses in comparison with the period before the treatment, as well as in comparison with the control group treated exclusively with Encorton in case of exacerbations.
ISSN:	0028-3843